Exploring the Therapeutic Potential of Aquaporin-4 Modulation in Sepsis: Inhibitors and Facilitators
International Journal of Molecular Sciences · 13.05.2026 · 27 (10) · 4333
DOI: 10.3390/ijms27104333 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2026. Verfasst von Alexandru Ionuț Neacșu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Aquaporin 4, Sepsis, Sepsis-Associated Encephalopathy, Niacinamide. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening syndrome driven by a dysregulated host response to infection and is frequently complicated by sepsis-associated encephalopathy (SAE), which contributes to long-term cognitive and neuropsychiatric sequelae. Despite advances in critical care, effective targeted therapies for SAE remain limited. Aquaporin-4 (AQP4), the predominant astrocytic water channel, plays a central role in cerebral water homeostasis, neuroinflammatory signaling, and blood–brain barrier integrity, suggesting its potential involvement in sepsis-induced cerebral dysfunction and neurorepair processes. Polymicrobial sepsis was induced in C57BL/6J mice using the cecal ligation and puncture (CLP) model. AQP4 activity was pharmacologically modulated through either inhibition or facilitation following sepsis induction. Disease severity was assessed using physiological parameters and a modified murine sepsis score. Neurological outcomes were evaluated through standardized behavioral tests assessing locomotor activity, motor coordination, cognitive performance, and depressive-like behavior. Neuroinflammatory and neuronal changes were examined by immunohistochemical analyses of microglial activation (Iba1), astroglial reactivity (GFAP), neuronal integrity (NeuN), and AQP4 expression. Compared with AQP4 facilitation, pharmacological inhibition of AQP4 was associated with a more favorable clinical recovery profile, reflected by lower sepsis severity scores and a more favorable body weight trajectory during the recovery phase. Behavioral analyses demonstrated preserved cognitive function, enhanced motor coordination, and reduced depressive-like behavior in AQP4 inhibitor-treated mice compared with animals receiving AQP4 facilitation. At the histological level, the inhibitor-treated group showed lower microglial and astroglial activation and better preservation of neuronal markers than the facilitator-treated group, whereas AQP4 facilitation exacerbated neuroinflammatory responses and neuronal alterations. These findings highlight a dual, context-dependent role of AQP4 in sepsis-associated cerebral dysfunction. These findings suggest that AQP4 modulation influences sepsis-associated cerebral dysfunction in a context-dependent manner. Within our experimental design, AQP4 facilitation was associated with worse outcomes, whereas AQP4 inhibition was associated with a comparatively more favorable neurobehavioral and histological profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Infectious Diseases and Pulmonology 'Victor Babes' Hospital, Bucharest Road, No.64 (ex 126), 200515 Craiova, Romania.
- Department of Infectious Diseases, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Experimental Research Center for Normal and Pathological Aging, Department of Functional Sciences, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Epidemiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
ORCID-Profile: Alexandru Ionuț Neacșu, Lucian-Ion Giubelan, Bogdan Cătălin, Alexandra Daniela Rotaru-Zăvăleanu, Elena-Mădălina Neniu, Daniel Pirici, Eugen Osiac
Förderung
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Neacșu, A. I., Giubelan, L. I., Cătălin, B., Rotaru-Zăvăleanu, A. D., Mușat, M. I., Neniu, E. M., Irimie, A. I., Pirici, D., & Osiac, E. (2026). Exploring the Therapeutic Potential of Aquaporin-4 Modulation in Sepsis: Inhibitors and Facilitators. International Journal of Molecular Sciences, 27(10), 4333. https://doi.org/10.3390/ijms27104333
Vancouver
Neacșu AI, Giubelan LI, Cătălin B, Rotaru-Zăvăleanu AD, Mușat MI, Neniu EM, et al. Exploring the Therapeutic Potential of Aquaporin-4 Modulation in Sepsis: Inhibitors and Facilitators. International Journal of Molecular Sciences. 2026;27(10):4333. doi:10.3390/ijms27104333
BibTeX
@article{Neacu2026,
author = {Neacșu, Alexandru Ionuț and Giubelan, Lucian-Ion and Cătălin, Bogdan and Rotaru-Zăvăleanu, Alexandra Daniela and Mușat, Mădălina Iuliana and Neniu, Elena-Mădălina and Irimie, Alexandru Ionuț and Pirici, Daniel and Osiac, Eugen},
title = {Exploring the Therapeutic Potential of Aquaporin-4 Modulation in Sepsis: Inhibitors and Facilitators},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4333},
doi = {10.3390/ijms27104333}
}
EUVIMED